8-K: Centrus Q3 2025 Net Income Rises, Boosted by $805M Notes

Centrus Energy Corp. reported a net income of $3.9 million for Q3 2025, a significant improvement from a net loss in the prior year, driven by increased revenue and a strengthened balance sheet from a convertible notes offering.

Summary

• Reported net income of $3.9 million ($0.21 basic, $0.19 diluted per common share) for the three months ended September 30, 2025, compared to a net loss of $5.0 million ($0.30 basic/diluted per common share) in Q3 2024.
• Total revenue increased by 30% to $74.9 million in Q3 2025 from $57.7 million in Q3 2024.
• LEU segment revenue increased by 29% to $44.8 million, with uranium revenue at $34.1 million. SWU revenue decreased by $24.1 million due to a 69% decrease in the average price of SWU sold.
• Technical Solutions segment revenue increased by 31% to $30.1 million, primarily due to a $7.3 million increase from the HALEU production contract with the Department of Energy (DOE).
• Recognized a gross loss of $4.3 million in Q3 2025, a change of $13.2 million from a gross profit of $8.9 million in Q3 2024.
• Strengthened the balance sheet and increased unrestricted cash balance to $1.6 billion.
• Closed an upsized and oversubscribed $805 million 0% convertible senior notes offering due August 2032, with net proceeds of approximately $782.4 million.
• Secured U.S. government waivers for 2026 and 2027 Russian committed deliveries.
• Signed an agreement with KHNP and POSCO International for potential investment to support the Piketon, Ohio, uranium enrichment plant expansion.
• Announced job hiring ahead of the planned expansion of the enrichment plant.
• Backlog is $3.9 billion as of September 30, 2025, extending to 2040, including approximately $3.0 billion for the LEU segment and $0.9 billion for the Technical Solutions segment.

Sentiment

Score: 8

Explanation: The filing reports a significant turnaround from a net loss to net income, substantial revenue growth, and a strengthened balance sheet through a successful capital raise. Strategic advancements in enrichment capacity and securing import waivers are strong positives. The gross loss and SWU price decrease are notable but overshadowed by overall financial improvement and strategic progress, indicating a very positive outlook despite some operational challenges.

Positives

• Shifted from a net loss of $5.0 million in Q3 2024 to a net income of $3.9 million in Q3 2025.
• Total revenue increased by 30% ($17.2 million) year-over-year to $74.9 million.
• LEU segment revenue increased by 29% ($10.0 million) year-over-year to $44.8 million.
• Technical Solutions segment revenue increased by 31% ($7.2 million) year-over-year to $30.1 million, primarily driven by the HALEU production contract.
• Unrestricted cash balance significantly increased to $1.6 billion, strengthening liquidity.
• Successfully closed an upsized and oversubscribed $805 million 0% convertible senior notes offering, generating $782.4 million in net proceeds.
• Secured U.S. government waivers for 2026 and 2027 Russian committed deliveries, de-risking future supply chains.
• Signed a strategic agreement with KHNP and POSCO International for potential investment in the Piketon, Ohio, uranium enrichment plant expansion, signaling strong growth prospects.
• Initiated job hiring for the planned enrichment plant expansion, indicating tangible progress on strategic growth initiatives.
• Maintained a strong backlog of $3.9 billion extending to 2040, including $2.3 billion in contingent LEU sales commitments for future production capacity.
• LEU SWU prices are near historic highs, indicating a favorable market environment and strong demand for enrichment services.

Negatives

• Gross profit shifted to a gross loss of $4.3 million in Q3 2025, a $13.2 million decrease from a gross profit of $8.9 million in Q3 2024.
• LEU segment gross profit shifted to a loss of $7.8 million in Q3 2025, a $13.0 million decrease from a profit of $5.2 million in Q3 2024, attributed to the composition of contracts.
• SWU revenue decreased by $24.1 million as a result of a 69% decrease in the average price of SWU sold.
• Technical Solutions segment gross profit decreased by $0.2 million (5%) to $3.5 million.
• Delay in completing Phase 2 of the HALEU Operation Contract, with costs incurred subsequent to November 2024 not yet subject to a fee as this portion remains undefinitized and subject to negotiation.

Risks

• Risks related to geopolitical conflicts and the imposition of sanctions or other measures by governments, organizations, or entities that could directly or indirectly impact financial position or ability to obtain, deliver, transport, or sell LEU or SWU components, especially under the existing supply contract with TENEX.
• Risks related to laws or other government measures that ban, delay, or restrict imports of Russian LEU into the United States, including the Prohibiting Russian Uranium Imports Act (effective August 11, 2024, subject to waivers) and Russian Federal Decree No. 1544.
• Potential inability to secure additional U.S. government waivers from the Import Ban Act in a timely manner or at all to continue importing Russian LEU under the TENEX Supply Contract.
• TENEX's refusal or its prohibition or inability to deliver, or timely deliver, LEU for any reason, including sanctions, inability to receive payments, or failure to secure export licenses.
• Risks related to laws, sanctions, or other government measures that prohibit or restrict doing business with TENEX.
• Risks related to disputes with third parties, including contractual counterparties, if timely deliveries of LEU are not received under the TENEX Supply Contract.
• Dependence on others, such as TENEX and Orano, and other suppliers (transporters, fabricators, converters) for goods and services, and any resulting negative impact on liquidity.
• Ability to sell, transport, or deliver procured LEU and the impacts of sanctions or limitations on imports, including those imposed under the 1992 Russian Suspension Agreement, international trade legislation, the Import Ban Act, and Russian Decree.
• Increasing quantities of LEU being imported into the United States from China and the impact on ability to make future LEU or SWU sales or finance enrichment capacity build-out.
• Risk related to changes in laws, tariffs, or other government measures that would lift, lower, or relax restrictions on LEU imports from Russia or other countries.
• Risks related to not being able to sell the Russian LEU available under the TENEX Supply Contract for import in 2026 or 2027.
• Risks related to whether or when government funding or demand for HALEU for government or commercial uses will materialize and at what level.
• Risks regarding funding for continuation and deployment of the American Centrifuge technology.
• Risks related to ability to perform and absorb costs under the HALEU Operation Contract, obtain new contracts and funding, and perform under other agreements.
• Risks that the full benefit of the HALEU Operation Contract may not be obtained, or the HALEU enrichment facility may not be operated to produce HALEU after contract completion, or its output may not be available as a future supply source.
• Risks related to existing or new trade barriers and contract terms that limit ability to procure LEU for, or sell, transport, or deliver LEU to, customers.
• Risks related to pricing trends and demand in the uranium and enrichment markets and their impact on profitability.
• Risks related to the movement and timing of customer orders.
• Significant competition from major LEU producers who may be less cost-sensitive or are wholly or partially government-owned.
• Limited ability to compete in foreign markets due to policies favoring indigenous suppliers.
• Revenue is largely dependent on largest customers.
• Risks related to backlog, including uncertainty concerning customer actions under current contracts and in future contracting attributable to market conditions, global events, or other factors, including lack of current production capability.
• Risks related to natural and other disasters, including the continued impact of the March 2011 earthquake and tsunami in Japan, on the nuclear industry and on business, results of operations, and prospects.
• Risks related to financial difficulties experienced by customers or suppliers, including possible bankruptcies, insolvencies, or other situations affecting their ability to pay for products or services.
• Risks related to pandemics, endemics, and other health crises.
• Risks related to the impact and potential extended duration of a supply/demand imbalance in the market for LEU.
• Risks related to DOE not issuing any major task orders to any contract awardee under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract.
• Risks related to not winning additional task orders under the HALEU Production Contract, LEU Production Contract, and HALEU Deconversion Contract to expand the capacity of the American Centrifuge plant.
• Risks related to DOE not providing an adequate share of appropriated funding under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract.
• Risks related to ability to secure financing to expand the plant for LEU or HALEU or expand it to a commercially viable level.
• Risks related to the DOE not exercising additional options under Phase 3 of the HALEU Operation Contract or awarding a third party to continue the HALEU Operation Contract.
• Risks related to inability to increase capacity for HALEU or LEU in a timely manner to meet market demand or contractual obligations.
• Risks related to DOE not awarding any contracts in response to future proposals.
• Risks related to reliance on the only firm that has the necessary permits and capability to transport LEU from Russia to the United States and that firm's ability to maintain those permits and capabilities or secure additional permits.
• Risks related to ongoing government shutdown or lack of funding that could result in program cancellations, disruptions, stop work orders, or limit the U.S. government's ability to make timely payments.
• Risks related to changes to the U.S. government's appropriated funding levels for the HALEU Operation Contract.
• Uncertainty regarding ability to commercially deploy competitive enrichment technology.
• Risks related to the potential for demobilization or termination of the HALEU Operation Contract.
• Risks that work obligated to be performed cannot be completed timely.
• Risks related to the government's inability to satisfy its obligations, including supplying government furnished equipment and processing security clearance applications.
• Risks related to inability to obtain the government's approval to extend the term or scope of permitted activities under the lease with the DOE in Piketon, Ohio.
• Risks related to security, including cybersecurity, incidents that may impact business operations.
• Risks related to inability to perform under fixed-price and cost-share contracts, including higher-than-expected costs and compliance with stringent government contractual requirements.
• Risks related to inability to attract qualified employees necessary for planned expansion of operations in Oak Ridge, Tennessee, or Piketon, Ohio.
• Risks related to long-term liabilities, including defined benefit pension plan obligations and postretirement health and life benefit obligations.
• Risks related to 0% and 2.25% Convertible Senior Notes maturing in 2030 and 2032, respectively.
• Risks of revenue and operating results fluctuating significantly from quarter to quarter, and in some cases, year to year.
• Risks related to the impact of financial market conditions on business, liquidity, prospects, pension assets, and insurance facilities.
• Risks related to the Company's capital concentration.
• Risks related to the value of intangible assets related to LEU segments backlog and customer relationships.
• Risks related to decisions made by Class B Common Stock stockholders, potentially based on factors unrelated to the Company's performance.
• Risks that a small number of Class A Common Stock holders may exert significant influence over the Company's direction.
• Risks related to the use of net operating losses (NOLs) carryforwards and net unrealized built-in losses (NUBILs) and the ability to generate taxable income to utilize them.
• Risks related to failures or security, including cybersecurity, breaches of information technology systems.
• Risks related to ability to attract and retain key personnel.
• Risks that new business opportunities cannot be obtained or market acceptance of products/services achieved, or that products/services become obsolete or noncompetitive.
• Risks related to actions (investigations, reviews, audits) by the U.S. government, Russian government, or other governments that could affect contractual performance.
• Risks related to inability to perform and receive timely payment under agreements with the DOE or other government agencies.
• Risks related to how aligned the Company may be, or perceived to be, with any political party, administration, or its policies.
• Risks related to changes or termination of agreements with the U.S. government or other counterparties, or the exercise of contract remedies, or the U.S. government's rights in intellectual property.
• Risks related to the competitive environment for products and services.
• Risks related to changes in the nuclear energy industry.
• Risks related to the competitive bidding process associated with obtaining contracts.
• Risks related to potential strategic transactions that could be difficult to implement, disrupt business, or change business profile significantly.
• Risks related to the outcome of legal proceedings and other contingencies (including lawsuits and government investigations or audits).
• Risks related to the impact of, or changes to, government regulation and policies or interpretation of laws or regulations.
• Risks related to the recent U.S. federal government administrations' reliance on executive orders to implement regulatory or trade policy and objectives.
• Risks of accidents during the transportation, handling, or processing of toxic hazardous or radioactive material.
• Risks associated with claims and litigation arising from past activities at sites currently operated or no longer operated, including the Paducah, Kentucky, and Portsmouth, Ohio, gaseous diffusion plants.

Future Outlook

Centrus is making significant progress in preparation for its enrichment build-out, aiming to offer a publicly-traded, American source of enrichment to meet commercial and national security needs, especially with LEU SWU prices near historic highs. The company intends to use the net proceeds from the convertible notes offering for general working capital, corporate purposes, investment in technology development or deployment, repayment or repurchase of outstanding debt, capital expenditures, potential acquisitions, and other business opportunities, including supporting the planned expansion of the Piketon, Ohio, uranium enrichment plant.

Management Comments

• "Centrus continued to build on its strong year-to-date financial results in the third quarter while making significant progress in preparation for our enrichment build-out." Amir Vexler, President and CEO.
• "We de-risked and strengthened our business across a number of initiatives, including securing U.S. government import waivers for our 2026 and 2027 committed deliveries, significantly expanding our cash balance, beginning to hire across our operations, and signing an agreement with KHNP and POSCO International to support our planned expansion." Amir Vexler, President and CEO.
• "With LEU SWU prices near historic highs, there is clear, accelerating market demand for a new U.S.-owned enrichment supply to service the domestic and global markets. Centrus is proud to offer a publicly-traded, American source of enrichment that can meet both the commercial and national security needs." Amir Vexler, President and CEO.

Industry Context

The announcement highlights accelerating market demand for new U.S.-owned enrichment supply, driven by LEU SWU prices near historic highs. This context underscores the strategic importance of Centrus's efforts to restore American uranium enrichment capabilities at scale, addressing both commercial and national security needs, especially given geopolitical risks and import restrictions on Russian LEU. The company's initiatives, such as the Piketon plant expansion and HALEU production, align with broader industry trends towards energy independence and advanced nuclear technologies.

Comparison to Industry Standards

• The filing mentions LEU SWU prices are near historic highs, indicating a favorable market environment for enrichment services compared to historical benchmarks.
• The company is leading the effort to restore America's uranium enrichment capabilities at scale, positioning itself as a key domestic supplier against international competitors like TENEX (Russia) and Orano (France), which are mentioned as existing suppliers.
• The HALEU production contract with the Department of Energy (DOE) positions Centrus as a critical player in developing fuel for advanced reactors, a growing segment of the nuclear industry.

Management Changes

Stakeholder Impact

• Shareholders: Positive impact due to improved financial performance (net income vs. loss), increased cash balance, strategic growth initiatives (Piketon expansion, HALEU production), and a strong backlog. The convertible notes offering could lead to dilution if converted.
• Employees: Positive impact due to announced job hiring ahead of planned enrichment plant expansion.
• Customers: Enhanced supply security and future capacity from U.S.-owned enrichment, especially with secured waivers for Russian deliveries and planned expansion.
• Creditors: Strengthened balance sheet and increased cash balance improve creditworthiness.
• Government/Regulators: Progress on HALEU production and U.S. enrichment capacity aligns with national energy security and clean energy goals.

Next Steps

• Continue preparation for enrichment build-out.
• Proceed with planned expansion of the Piketon, Ohio, uranium enrichment plant.
• Continue job hiring for the enrichment plant expansion.
• Negotiate fee for the undefinitized portion of Phase 2 of the HALEU Operation Contract.
• Potentially utilize net proceeds from convertible notes for technology development, debt management, capital expenditures, and acquisitions.

Key Dates

Recommendation

The company has demonstrated a significant financial turnaround, moving from a net loss to a net income, coupled with substantial revenue growth. The successful $805 million convertible notes offering has dramatically strengthened the balance sheet, providing ample liquidity for strategic initiatives. Key de-risking actions, such as securing waivers for Russian uranium deliveries and forging a strategic investment agreement for the Piketon plant expansion, position Centrus favorably in a market with high LEU SWU prices and increasing demand for domestic enrichment. While there was a gross loss in the quarter and a delay in a HALEU contract phase, the overall strategic progress, robust backlog, and improved financial health suggest strong future growth potential and a compelling investment opportunity in the critical nuclear fuel sector.

Keywords

Centrus Energy, LEU, HALEU, Uranium Enrichment, Nuclear Fuel, SEC Filing, Q3 2025 Earnings, Convertible Notes, Piketon Ohio, DOE Contract, Nuclear Energy, Energy Security, Financial Results, LEU SWU prices, Russian Uranium Imports Act, TENEX